Table 1.
Patient Demographics, comparing those under and over 65 years
| < 65 years | ≥ 65 years | Total | p value | |
|---|---|---|---|---|
| Included patients n (%) | 153 (45.3) | 185 (54.7) | 338 (100) | |
| Age, years, mean (SD) | 47 (12) | 79 (8.0) | 65 (18) | < 0.001 |
| Sex, Female n (%) | 91 (59.5) | 91 (49.2) | 182 (53.8) | 0.075 |
| Charlson Comorbidity Index, median (IQR) | 1.0 (0.0–2.0) | 4.0 (4.0–6.0) | 3.0 (1.0–5.0) | < 0.001 |
| Age-adjusted Charlson Comorbidity Index, median (IQR) | 3.0 (1.0–4.0) | 9.0 (7.0–11.0) | 6.0 (3.0–9.0) | < 0.001 |
| BMI (kg/m2), mean (SD) | 29.6 (7.2) | 27.3 (6.2) | 28.3 (6.8) | 0.002 |
| ASA, n (%) | < 0.001 | |||
| 1 | 53 (35.1) | 9 (4.9) | 62 (18.6) | |
| 2 | 74 (49.0) | 75 (41.2) | 149 (44.7) | |
| 3 | 18 (11.9) | 77 (42.3) | 95 (28.5) | |
| 4 | 6 (4.0) | 21 (11.5) | 27 (8.1) | |
| Diagnosis, n (%) | 0.065 | |||
| Cholecystitis | 68 (44.4) | 86 (46.5) | 154 (45.6) | |
| Gallstone pancreatitis | 40 (26.1) | 31 (16.8) | 71 (21.0) | |
| CBD stone | 25 (16.3) | 36 (19.5) | 61 (18.0) | |
| Cholangitis | 16 (10.5) | 31 (16.8) | 47 (13.9) | |
| Mirizzi syndrome or bilioenteric fistula | 4 (2.6) | 1 (0.5) | 5 (1.5) | |
| AAST Cholecystitis Grade, n (%) | 0.048 | |||
| 1 | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | |
| 2 | 58 (85.3%) | 66 (76.7%) | 124 (80.5%) | |
| 3 | 4 (5.9%) | 15 (17.4%) | 19 (12.3%) | |
| 4 | 6 (8.8%) | 3 (3.5%) | 9 (5.8%) | |
| 5 | 0 (0.0%) | 2 (2.3%) | 2 (1.3%) | |
| Grade 3 or higher | 10.0 (14.7%) | 20.0 (23.3%) | 30.0 (19.5%) | 0.1831 |
| AAST Pancreatitis Grade, n (%) | 0.542 | |||
| 1 | 31 (81.6) | 26 (83.9) | 57 (82.6) | |
| 2 | 6 (15.8) | 4 (12.9) | 10 (14.5) | |
| 3 | 0 (0.0) | 1 (3.2) | 1 (1.4) | |
| 4 | 1 (2.6) | 0 (0.0) | 1 (1.4) |